Caring for Patients with Rectal Cancer During the COVID-19 Pandemic

Skowron, Kinga B.; Hurst, Roger D.; Umanskiy, Konstantin; Hyman, Neil; Shogan, Benjamin D.

doi:10.1007/s11605-020-04645-z

Cited by 16 publications

(15 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, prioritizing oncologic procedures and treatments, over procedures performed for non-malignant indications should allow for prompt and timely surgical intervention. This task will become harder as there is a backlog of rectal cancer patients whose care will further strain an already burdened healthcare system still dealing with the pandemic 34 . Long-term oncological outcomes will need to be reviewed in future to further elucidate the impact of the COVID-19 pandemic on rectal cancer treatment.…”

Section: Discussionmentioning

confidence: 99%

The effect of the first year of the COVID-19 pandemic on sphincter preserving surgery for rectal cancer: A single referral center experience

Freund

Kent

Horesh

et al. 2022

Surgery

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The effect of the first year of the COVID-19 pandemic on sphincter preserving surgery for rectal cancer: A single referral center experience

Freund

Kent

Horesh

et al. 2022

Surgery

View full text Add to dashboard Cite

“…Other studies concurred these results showing that many of the more seriously affected patients with COVID-19 were elderly. Same is true for cancer as it is predominately a disease of the elderly [ 10 ]. However, the average age of our patients was 74.2 ± 7 years, which was higher than the average age of patients in pre-COVID era.…”

Section: Discussionmentioning

confidence: 99%

Comparison of Colorectal Cancer Surgery Services During COVID-19 First Wave With Pre-COVID Time

Rashid¹,

Raza²,

Thomas³

et al. 2021

Cureus

View full text Add to dashboard Cite

The first confirmed case of COVID-19 in the United Kingdom (UK) was reported on 29 January 2020. The country saw the peak of infection between March and May of 2020. The result was a change in the practice of how we treat most surgical conditions including cancer. We continued providing service to our colorectal cancer patients at a District General Hospital. The aim of this study was to compare our provision of colorectal cancer service during the peak of the pandemic to that of the pre-COVID time in our hospital. MethodsWe collected data of all colorectal cancer patients who underwent surgery between 1 March 2020 and 30 April 2020 in our hospital. The comparative data were collected for similar patients during the same time frame in 2019. A detailed data set was compiled on Microsoft Excel (Microsoft Corp, Washington) and analysed using IBM SPSS Statistics for Windows, Version 21.0 (Released 2012. IBM Corp, Armonk, NY). ResultsThe two groups were comparable in demographics including age, BMI, gender, and Charlson comorbidity index. Time from decision-to-treat to surgery, post-operative HDU/ITU stay, and overall length of stay was shorter in the COVID group than the Pre-COVID group without any significant statistical difference. There was no statistically significant difference between the two groups in Calvien-Dindo complications grade 1 and 2. No mortality was reported due to direct or indirect consequences of COVID-19 infection. More open procedures were performed in our department during the first wave of COVID-19 in the UK compared to Pre-COVID time. ConclusionsDespite the challenges we faced during the peak of the COVID-19 pandemic, we managed to provide standard care to our colorectal cancer patients with comparable post-operative surgical and oncological outcomes.

show abstract

“…The usual practice is to consider surgery within 3 to 7 days or 4 weeks of SCRT and 6 weeks of LCRT. A delay after radiation has benefits in COVID scenario where scheduling of surgery may be difficult due to resource and staff constraints 38 . The delay will help in down‐staging, particularly in cases of distal cancers (< 5 cm from the anal verge), as shown in the Stockholm trial.…”

Section: Discussionmentioning

confidence: 99%

Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic

Lewis

Talapatra

2020

Cancer Reports

View full text Add to dashboard Cite

Background COVID‐19 outbreak was declared as a pandemic by the World Health Organization in March 2020. Over the last 3 months, the pandemic has challenged the diagnosis and treatment of all cancer, including rectal cancer. Constraints in resources call for a change in the treatment strategy without compromising efficacy. Recent Findings Delivery of shorter treatment schedules for radiotherapy offers advantages like short overall treatment time, improved throughput on the machine, improved compliance and reduced risk of transmission of COVID 19. Other strategies include delaying surgery, reducing the intensity of chemotherapy and adoption of organ preservation approach. Conclusion The curative treatment of rectal cancer should not be hindered during the COVID pandemic, and modifications in the multi‐modality treatment will help achieve quality care.

show abstract

Caring for Patients with Rectal Cancer During the COVID-19 Pandemic

Cited by 16 publications

References 42 publications

The effect of the first year of the COVID-19 pandemic on sphincter preserving surgery for rectal cancer: A single referral center experience

The effect of the first year of the COVID-19 pandemic on sphincter preserving surgery for rectal cancer: A single referral center experience

Comparison of Colorectal Cancer Surgery Services During COVID-19 First Wave With Pre-COVID Time

Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic

Contact Info

Product

Resources

About